The researchers discovered that the glycoprotein RPTP zeta S3L was connecting to more CD33 receptors than healthy brains, limiting the brain’s ability to clean up harmful proteins. Alzheimer’s ...
Initial data from the Phase 1 trial expected in 2025SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ...